Dedienne Santé SA, headquartered in France, is a prominent player in the medical device industry, specialising in innovative solutions for the healthcare sector. Founded in 1992, the company has established a strong presence across Europe and beyond, focusing on the development and manufacturing of high-quality surgical instruments and medical devices. With a commitment to excellence, Dedienne Santé offers a diverse range of products, including advanced surgical tools and customised solutions that cater to the specific needs of healthcare professionals. Their unique approach combines cutting-edge technology with a deep understanding of clinical requirements, ensuring optimal performance and reliability. Recognised for its dedication to quality and innovation, Dedienne Santé has achieved significant milestones, positioning itself as a trusted partner in the medical community. The company continues to enhance its market presence through ongoing research and development, solidifying its reputation as a leader in the medical device sector.
How does Dedienne Santé SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Dedienne Santé SA's score of 26 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Dedienne Santé SA, headquartered in France, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is classified as a current subsidiary and does not inherit emissions data from a parent organization. Consequently, there are no reported Scope 1, 2, or 3 emissions figures available. In terms of climate commitments, Dedienne Santé SA has not outlined any specific reduction targets or initiatives. The lack of documented climate pledges or participation in frameworks such as the Science Based Targets initiative (SBTi) suggests that the company may still be in the early stages of developing its climate strategy. As the industry increasingly prioritises sustainability, Dedienne Santé SA may benefit from establishing clear emissions reduction goals and engaging in recognised climate initiatives to enhance its environmental impact and align with global climate action efforts.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Dedienne Santé SA has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
